Safety and efficacy of carvedilol in severe heart failure
Open Access
- 1 September 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 3 (3) , 173-179
- https://doi.org/10.1016/s1071-9164(97)90013-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitorThe American Journal of Cardiology, 1994
- Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).Circulation, 1993
- Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart FailureNew England Journal of Medicine, 1993
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1991
- Xamoterol in severe heart failureThe Lancet, 1990
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Pirbuterol: A new oral sympathomimetic amine for the treatment of congestive heart failureAmerican Heart Journal, 1981
- Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.Heart, 1980
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978